Skip to main content
Indian stocks: Visit www.stage2stocks.com →

Medline Inc. Class A

Stage 4 · Declining · week 3

As of Oct 22, 2026, Medline is in Stage 4, the downtrend phase, now in week 3 (since Oct 5, 2026). It closed at $34.88, below its 200-day average.

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. More about the company

$34.88
-0.20% today
$46.9B · Large cap
Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Accelerating ⇈

Edge

—

Is MDLN early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2025-12-17 → 2026-10-22
S? 41w
2025-12-172026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S? 41w → S4 3w current
Total tracked: 44 weeks across 2 stage runs.

MDLN among Medical Instruments & Supplies50th of 51 by relative strength

All 51 →
Stocks in Medical Instruments & Supplies ranked by relative strength, with stage and one-month change
#StockStageRS1M
1PLSEStage 2 · wk 3498+1.3%
2PDEXStage 2 · wk 3697−13.3%
3HBIOStage 2 · wk 1195+3.6%
4ATRCStage 2 · wk 1089−1.1%
5WSTStage 2 · wk 2482+4.8%
6BDXStage 2 · wk 1181+9.8%
7ICUIStage 3 · wk 181+3.1%
8OSURStage 3 · wk 875−4.8%
…50MDLNStage 4 · wk 3—+1.7%
vs 52W High
—
In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.
Stage Maturity
Week 3
1w13w26w
Week 3, early Stage 4 decline
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.
vs 200 DMA
-12.6%
200 DMA: $39.92
In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.
Rel Volume
1.93x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.
Trend Health
↑ ⇈
Short-term trend rising strongly, and accelerating
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+1.7%
3M
-10.0%
6M
-24.6%
YTD
-14.1%
1Y
—
Scan Membership
Not in any current scan.
Recent Stage Timeline
2026-10-22S4
Wk 3 · Vol 1.93x
2026-10-21S4
Wk 3 · Vol 0.91x
2026-10-20S4
Wk 3 · Vol 1.23x
2026-10-19S4
Wk 3 · Vol 0.99x
2026-10-16S4
Wk 2 · Vol 0.89x
2026-10-15S4
Wk 2 · Vol 0.93x
2026-10-14S4
Wk 2 · Vol 0.56x
2026-10-13S4
Wk 2 · Vol 0.52x
2026-10-12S4
Wk 2 · Vol 0.48x
2026-10-09S4
Wk 1 · Vol 0.64x
2026-10-08S4
Wk 1 · Vol 1.24x
2026-10-07S4
Wk 1 · Vol 0.54x
Moving averages & range
50 DMA
$34.70
200 DMA
$39.92
52W High
—
52W Low
—
5D Low
$34.88
Resistance levels (recent highs)
20d High
$36.57
60d High
$42.04
120d High
$45.32
250d High
—
Next resistance
+4.8%
to 20d High
P/E (TTM)
87.2
Forward 22.2
Earnings Growth (YoY)
+262.0%
Revenue +11.6%
ROE
+4.9%
Profit margin +2.3%
Dividend Yield
0.00%
P/B 2.6

Medline: quick answers

What stage is Medline in?

As of Oct 22, 2026, Medline (MDLN) is in Stage 4, the downtrend phase. It entered Stage 4 on Oct 5, 2026 and is in week 3. What the four stages mean

Is Medline in an uptrend?

No. Medline is in a Stage 4 downtrend. It trades 12.6% below its 200-day average.

How has Medline performed over the past year?

As of Oct 22, 2026, Medline is down 14.1% so far in 2026.

Which sector and industry is Medline in?

Medline is in the Medical Instruments & Supplies industry, part of the Health Care sector.

About this companyHealth Care· Medical Instruments & Supplies

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services, such as consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. The company was founded in 1966 and is based in Northfield, Illinois.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.